business

Cantor Fitzgerald reiterates Bicara Therapeutics stock rating

Investing.com · May 27, 2026, 12:20 PM · Also reported by 2 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Cantor Fitzgerald Reaffirms Overweight Rating on Visa (V) After Earnings Beat Yahoo Finance KeyBanc Reiterates Overweight Rating on Microsoft (MSFT) on Azure and Copilot Growth

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Cantor Fitzgerald reiterates Bicara Therapeutics stock rating

Also covered by

More in business